Michael A Weil
Nursing at Quemoy Way, Denver, CO
License number
Colorado 505228
Issued Date
Feb 8, 2000
Renew Date
Feb 1, 2002
Expiration Date
Jan 31, 2004
Type
Certified Nurse Aide
Address
Address
5748 S Quemoy Way S. Quemoy Way, Denver, CO 80015
Professional information
Pharmaceutically Enhanced Low-Energy Radiosurgery
US Patent:
6366801, Apr 2, 2002
Filed:
Apr 14, 2000
Appl. No.:
09/550498
Inventors:
Michael D. Weil - Golden CO
Assignee:
Sirius Medicine, LLC - Golden CO
International Classification:
A61B 600
US Classification:
600431, 378 65
Abstract:
Contrast agents developed specifically for x-ray diagnostics provide dose-enhanced radiotherapy and radiosurgery. The presence of heavy elements from these contrast agents, even small quantities, leads to a major dose increase in target tissue. When combined with in vivo calibration of the amount of contrast agent, the procedure is quick, accurate, and safe. The technique can also be used in combination with other techniques, such as focused x-rays, to achieve further enhancement of therapeutic ratio. Through optimization of the equipment it is possible to achieve very large ratios of dose in target to dose in healthy tissue, up to 10:1.
Pharmaceutically Enhanced Low-Energy Radiosurgery
US Patent:
6125295, Sep 26, 2000
Filed:
Aug 27, 1998
Appl. No.:
9/140981
Inventors:
Webster C. Cash - Boulder CO
Michael D. Weil - Golden CO
Michael D. Weil - Golden CO
International Classification:
A61B 600
US Classification:
600431
Abstract:
Contrast agents developed specifically for x-ray diagnostics provide dose-enhanced radiotherapy and radiosurgery. The presence of heavy elements from these contrast agents, even small quantities, leads to a major dose increase in target tissue. When combined with in vivo calibration of the amount of contrast agent, the procedure is quick, accurate, and safe. The technique can also be used in combination with other techniques, such as focused x-rays, to achieve further enhancement of therapeutic ratio. Through optimization of the equipment it is possible to achieve very large ratios of dose in target to dose in healthy tissue up to 10:1.